Evidence map›Paper›PMID 31514470›Full record

ArticleCells2019

A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia.

Nejla Erkilic, Vincent Gatinois, Simona Torriano, Pauline Bouret, Carla Sanjurjo-Soriano, Valerie De Luca, Krishna Damodar, Nicolas Cereso, Jacques Puechberty, Rocio Sanchez-Alcudia and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Nejla ErkilicInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Vincent GatinoisChromosomal Genetics Unit, Chromostem Platform, CHU, Montpellier, France.
Simona TorrianoInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Pauline BouretChromosomal Genetics Unit, Chromostem Platform, CHU, Montpellier, France.
Carla Sanjurjo-SorianoInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Valerie De LucaInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Krishna DamodarInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Nicolas CeresoInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Jacques PuechbertyService of Clinical Genetics, Department of Medical Genetics, Rare Diseases and Personalized Medicine, CHU, Montpellier, France.
Rocio Sanchez-AlcudiaDepartment of Genetics, Institute for Sanitary Investigation, Foundation Jimenez Diaz, 28040 Madrid, Spain.
Christian P HamelInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Carmen AyusoDepartment of Genetics, Institute for Sanitary Investigation, Foundation Jimenez Diaz, 28040 Madrid, Spain.
Isabelle MeunierInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France.
Franck PellestorChromosomal Genetics Unit, Chromostem Platform, CHU, Montpellier, France.
Vasiliki KalatzisInserm U1051, Institute for Neurosciences of Montpellier, 34091 Montpellier CEDEX 5, France. vasiliki.kalatzis@inserm.fr.
Inserm · FRCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) have revolutionized the study of human diseases as they can renew indefinitely, undergo multi-lineage differentiation, and generate disease-specific models. However, the difficulty of working with iPSCs is that they are prone to genetic instability. Furthermore, genetically unstable iPSCs are often discarded, as they can have unforeseen consequences on pathophysiological or therapeutic read-outs. We generated iPSCs from two brothers of a previously unstudied family affected with the inherited retinal dystrophy choroideremia. We detected complex rearrangements involving chromosomes 12, 20 and/or 5 in the generated iPSCs. Suspecting an underlying chromosomal aberration, we performed karyotype analysis of the original fibroblasts, and of blood cells from additional family members. We identified a novel chromosomal translocation t(12;20)(q24.3;q11.2) segregating in this family. We determined that the translocation was balanced and did not impact subsequent retinal differentiation. We show for the first time that an undetected genetic instability in somatic cells can breed further instability upon reprogramming. Therefore, the detection of chromosomal aberrations in iPSCs should not be disregarded, as they may reveal rearrangements segregating in families. Furthermore, as such rearrangements are often associated with reproductive failure or birth defects, this in turn has important consequences for genetic counseling of family members.

Indexed as

Cell DifferentiationCells, CulturedCellular ReprogrammingChoroideremiaChromosomes, Human, Pair 12Chromosomes, Human, Pair 20Chromosomes, Human, Pair 5HumansInduced Pluripotent Stem CellsKaryotypeRetinal DystrophiesSiblingsTranslocation, Geneticchoroideremiagenetic instabilityinduced pluripotent stem cellsinherited retinal dystrophiesretinal differentiationunderprenylated cell phenotype

Identifiers

PMID31514470
PMCPMC6770680
OpenAlexW2972809611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.